Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05126862 · ClinicalTrials.gov registry record · NA

Measurement and Modification of Threat Interpretation Bias in Neurodegenerative Movement Disorders (Aims 2 & 3)

A NA study, sponsored by University of Virginia.

Completed
Registry status
NA
Development phase
43
Enrollment target

NCT05126862 is a NA study that has completed, run by University of Virginia. The registered enrollment target is 43 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05126862, a NA study, has completed, sponsored by University of Virginia.

COMPLETED
Registry status
NA
Development phase
43 participants
Enrollment target

Study Summary

The purpose of this study is conduct a pilot open trial of a web-based cognitive bias modification intervention to reduce anxiety symptoms in persons with Huntington's disease and persons with Parkinson's disease.

Interventions

  • BEHAVIORAL MindTrails

Trial Details

FieldValue
Enrollment Target 43 participants
Start Date 2021-12-10
Est. Completion 2023-07-09
Phase NA

Sponsor

University of Virginia

449 total trials

What the Registry Record Tells You About NCT05126862

The ClinicalTrials.gov registry entry for NCT05126862 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which MindTrails is the first listed.

NCT05126862 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05126862 about?

NCT05126862 is a clinical study titled "Measurement and Modification of Threat Interpretation Bias in Neurodegenerative Movement Disorders (Aims 2 & 3)". The purpose of this study is conduct a pilot open trial of a web-based cognitive bias modification intervention to reduce anxiety symptoms in persons with Huntington's disease and persons with Parkinson's disease.

What is the current status of trial NCT05126862?

This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2021-12-10. Estimated completion is 2023-07-09.

What interventions are being tested in trial NCT05126862?

The interventions under investigation include: MindTrails (BEHAVIORAL).

Who is sponsoring clinical trial NCT05126862?

This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.